Venus Remedies has received regulatory approval in Indonesia for ceftazidime+avibactam, enabling the country’s first generic launch and marking the company’s entry into the anti-infective segment in the key ASEAN market.
Bristol Myers Squibb today reported positive Phase 3 results for Camzyos in adolescents with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). The data come from the Phase 3 SCOUT-HCM trial, the first study of a cardiac myosin inhibitor...
Novartis to build its fourth US radioligand therapy facility in Florida, boosting RLT supply, ensuring timely cancer treatment, and expanding its $23 billion US investment.
PharmNXT Biotech expands globally after acquiring Ireland’s DTR, adding GMP modular tubing tech to boost bioprocess efficiency, safety, and exports from India to Europe and Asia.
Panacea Biotec shares rise over 9% after completing Phase III enrollment for its dengue vaccine DengiALL, a potential first indigenous single-shot dengue vaccine in India.
Dr. Lal PathLabs Limited today announced the launch of the Sovaaka Diagnostic Experience Centre in Gurugram, marking a major step in the evolution of preventive healthcare in India. The launch was graced by Haryana Chief Minister Nayab Singh...
Torrent Pharma approves Rs 12,500 crore NCD issue to boost liquidity, fund acquisitions and capex, while maintaining strong balance sheet, low leverage, and long-term growth focus.
Bristol Myers Squibb positions India as a growth engine, investing in AI-led pharma commercialization, pipeline expansion, and faster market adoption across oncology and cardiology.
India pharma partnerships in 2025 are accelerating innovation, patient care, digital transformation, and market leadership through strategic alliances across R&D, tech, and supply chains.
Emcure Pharmaceuticals has announced a nationwide rollout of its obesity drug Poviztra, marking a focused push into India’s expanding weight-management market. The company plans to move beyond a metro-centric strategy and build demand across Tie...
.jpg)
, CDSCO.jpg)